Clinical Trial Update: Micronized dHACM Injectable for the Treatment of Plantar Fasciitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of micronized dHACM injectable for plantar fasciitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fasciitis
• Plantar Fasciitis

Drugs mentioned

• micronized dHACM injectable (dHACM injectable (micronized))

Snippet

Sponsor: MiMedx Group, Inc. | Conditions: Fasciitis, Plantar | Phase 3 | Status: COMPLETED